Advanced search
Publication Cover
Clinical Ophthalmology Volume 15, 2021 - Issue
Submit an article Journal homepage
93
Views
1
CrossRef citations to date
0
Altmetric
Original Research

US Health Resource Utilization and Cost Burden Associated with Choroideremia

Shaobin Dong1 Value and Access, Biogen, Cambridge, MA, USACorrespondence[email protected]
View further author information
,
Nicole Tsao2 Medical Health Outcomes and Research, Biogen, Cambridge, MA, USAView further author information
,
Qiang Hou1 Value and Access, Biogen, Cambridge, MA, USAView further author information
,
Duygu Bozkaya1 Value and Access, Biogen, Cambridge, MA, USAView further author information
&
Bart P Leroy3 Department of Ophthalmology & Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium;4 Department of Head & Skin, Ghent University, Ghent, Belgium;5 Division of Ophthalmology & Center for Cellular & Molecular Therapeutics, The Children’s Hospital of Philadelphia, Philadelphia, PA, USAORCID Iconhttps://orcid.org/0000-0002-9899-2081View further author information
ORCID Icon
Pages 3459-3465 | Published online: 14 Aug 2021

References

  • Freund PR, Sergeev YV, MacDonald IM. Analysis of a large choroideremia dataset does not suggest a preference for inclusion of certain genotypes in future trials of gene therapy. Mol Genet Genomic Med. 2016;4:344–358. doi:10.1002/mgg3.208
  • Heon E, Alabduljalil T, McGuigan ID, et al. Visual function and central retinal structure in choroideremia. Invest Ophthalmol Vis Sci. 2016;57:377–387. doi:10.1167/iovs.15-18421
  • Zinkernagel MS, MacLaren RE. Recent advances and future prospects in choroideremia. Clin Ophthalmol. 2015;9:2195–2200. doi:10.2147/OPTH.S65732
  • Pennesi ME, Birch DG, Duncan JL, Bennett J, Girach A. Choroideremia: retinal degeneration with an unmet need. Retina. 2019;39:2059–2069. doi:10.1097/IAE.0000000000002553
  • Qiu M, Wang SY, Singh K, Lin SC. Association between visual field defects and quality of life in the United States. Ophthalmology. 2014;121:733–740. doi:10.1016/j.ophtha.2013.09.043
  • Scott AW, Bressler NM, Ffolkes S, Wittenborn JS, Jorkasky J. Public attitudes about eye and vision health. JAMA Ophthalmol. 2016;134:1111–1118. doi:10.1001/jamaophthalmol.2016.2627
  • Brezin AP, Lafuma A, Fagnani F, Mesbah M, Berdeaux G. Prevalence and burden of self-reported blindness, low vision, and visual impairment in the French community: a nationwide survey. Arch Ophthalmol. 2005;123:1117–1124. doi:10.1001/archopht.123.8.1117
  • Latham K, Baranian M, Timmis M, Pardhan S. Emotional health of people with visual impairment caused by retinitis pigmentosa. PLoS One. 2015;10(12):e0145866. doi:10.1371/journal.pone.0145866
  • Chuvarayan Y, Finger RP, Koberlein-Neu J. Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study. Eur J Health Econ. 2020;21:115–127. doi:10.1007/s10198-019-01115-5
  • Koberlein J, Beifus K, Schaffert C, Finger RP. The economic burden of visual impairment and blindness: a systematic review. BMJ Open. 2013;3:e003471. doi:10.1136/bmjopen-2013-003471
  • Wittenborn JS, Zhang X, Feagan CW, et al. The economic burden of vision loss and eye disorders among the United States population younger than 40 years. Ophthalmology. 2013;120:1728–1735. doi:10.1016/j.ophtha.2013.01.068
  • Deloitte Access Economics. The socioeconomic impact of inherited retinal dystrophies (IRDs) in the United States of America (US); 2020. Available from: https://retina-kyc.org/wp-content/uploads/2020/10/DAE-Retina-International-US-Final-Report_20201008_FINAL.pdf. Accessed December 1, 2020.
  • Jensen IS, Zacherle E, Blanchette C, Kay CN. Estimating the life-time indirect costs of vision impairment in inherited retinal degeneration: economic impact on education, government benefit programs, productivity, and tax loss for patients and caregiver burden. Presented at: American Academy of Ophthalmology Annual Meeting; October 28–30; 2018; Chicago, IL.
  • Lima Cunha D, Richardson R, Tracey-White D, et al. REP1 deficiency causes systemic dysfunction of lipid metabolism and oxidative stress in choroideremia. JCI Insight. 2021;6:e146934. doi:10.1172/jci.insight.146934
  • Cheng Q, Saaddine JB, Klein R, Rothenberg R, Chou CF, Il’yasova D. Early age-related macular degeneration with cardiovascular and renal comorbidities: an analysis of the national health and nutrition examination survey, 2005–2008. Ophthalmic Epidemiol. 2017;24:413–419. doi:10.1080/09286586.2017.1337911
  • Liao D, Mo J, Duan Y, et al. Is age-related macular degeneration associated with stroke among elderly Americans? Open Ophthalmol J. 2008;2:37–42. doi:10.2174/1874364100802010037
  • Zlateva GP, Javitt JC, Shah SN, Zhou Z, Murphy JG. Comparison of comorbid conditions between neovascular age-related macular degeneration patients and a control cohort in the medicare population. Retina. 2007;27:1292–1299. doi:10.1097/01.iae.0000300915.81866.b8
  • Lee MS, Kuo LL, Tan EC, Lee OK. Is normal-tension glaucoma a risk factor for stroke? A 10-year follow-up study. PLoS One. 2017;12:e0179307. doi:10.1371/journal.pone.0179307
  • MacDonald IM, Hume S, Chan S, et al. Choroideremia. In: Adam MP, Ardinger HH, Pagon RA, et al. editors. GeneReviews. Seattle: University of Washington; 2020.
  • Jauregui R, Park KS, Tanaka AJ, et al. Spectrum of disease severity and phenotype in chroideremia carriers. Am J Ophthalmol. 2019;207:77–86. doi:10.1016/j.ajo.2019.06.002
  • McLaren TL, De Roach JN, Thompson JA, et al. Expanding the genetic spectrum of choroideremia in an Australian cohort: report of five novel CHM variants. Hum Genome Var. 2020;7:35. doi:10.1038/s41439-020-00122-w

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.